Abstract
Cisplatin is an antineoplastic agent largely used and related to bilateral and irreversible hearing loss in patients. Generation of reactive oxygen species (ROS) by cisplatin induces cochlear inflammation and apoptosis of cochlear cells. Thus, therapeutic strategies seeking to reduce auditory dysfunction through the prevention of inflammation have been studied. In this context, we highlig…